Abstract

Human papillomavirus (HPV) vaccination has revolutionized cervical cancer prevention by reducing the incidence of high-risk HPV infections, which are the primary cause of cervical cancer. This study evaluates the impact of HPV vaccination on cervical cancer incidence through a cross-sectional analysis of epidemiological data. The findings highlight vaccination coverage, demographic variations, and the correlation between immunization rates and cancer trends. Understanding these dynamics is essential for optimizing vaccination programs, addressing disparities, and enhancing global cervical cancer prevention strategies.